Metabolic side effects with second generation antipsychotics in antipsychotic-naive adolescents

被引：0
|
作者：
Fraguas, D. [1 ]
Laita, P. [1 ]
Parellada, M. [1 ]
Moreno, D. [1 ]
Cifuentes, A. [1 ]
Ulloa, A. [1 ]
Lozano, R. [1 ]
Arango, C. [1 ]
机构：
[1] Hosp Gen Univ Gregorio Maranon, Madrid, Spain
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2007年 / 17卷
关键词：
D O I：
10.1016/S0924-977X(07)70083-4
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S71 / S71
页数：1
相关论文
共 50 条
  • [21] Review: metabolic side effects of second-generation antipsychotics
    Johnsen, Erik
    [J]. EVIDENCE-BASED MENTAL HEALTH, 2011, 14 (02) : 47 - 47
  • [22] Antipsychotic-induced weight gain in antipsychotic-naive adolescents
    Parellada, M.
    Fraguas, D.
    Ruiz-Sancho, A.
    Moreno, D.
    Cifuentes, A.
    Ulloa, A.
    Lozano, R.
    Arango, C.
    [J]. SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 452 - 452
  • [23] 3-Month, prospective evaluation of cardiometabolic effects of second-generation antipsychotics in antipsychotic-naive and -exposed youth with severe mental disorders
    Carbon-Correll, M.
    Guinart, D.
    Kane, J.
    Correll, C.
    [J]. EUROPEAN PSYCHIATRY, 2020, 63 : S76 - S77
  • [24] Metabolic side effects and pharmacogenetics of second-generation antipsychotics in children
    Devlin, Angela M.
    Panagiotopoulos, Constadina
    [J]. PHARMACOGENOMICS, 2015, 16 (09) : 981 - 996
  • [25] Short-term weight gain in antipsychotic-naive pediatric and adult patients with psychosis treated with second-generation antipsychotics
    Roventa, C.
    Diaz-Caneja, C. M.
    Pina-Camacho, L.
    Fraguas, D.
    Saiz, P. A.
    Corripio, I.
    Rodriguez-Jimenez, R.
    Gonzalez-Pinto, A.
    Sanjuan, J.
    Garcia-Lopez, A.
    Arias, B.
    Baeza, I.
    Alda, J. A.
    Martinez-Cantarero, C.
    Merchan-Naranjo, J.
    Arango, C.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S570 - S570
  • [26] Predictors of second-generation antipsychotic-induced weight gain: a longitudinal study on antipsychotic-naive patients
    Sanchez, M. Bravo
    Pina-Camacho, L.
    Diaz-Caneja, C. M.
    Alvarez Blazquez, M.
    Arias, B.
    Bobes, J.
    Corripio, I.
    Rodriguez-Jimenez, R.
    Fraguas, D.
    Arango, C.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S64 - S65
  • [27] New-onset dyslipldemia in antipsychotic-naive youngsters treated with atypical antipsychotics
    Correll, CU
    Parikh, UH
    Mughal, T
    Kane, JM
    Malhotra, AK
    [J]. BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 36S - 36S
  • [28] Antipsychotics Associated with the Development of Type 2 Diabetes in Antipsychotic-Naive Schizophrenia Patients
    Nielsen, Jimmi
    Skadhede, Soren
    Correll, Christoph U.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2010, 35 (09) : 1997 - 2004
  • [29] Weight gain in antipsychotic naive patients and metabolic side effects
    Tarricone, I
    Gozzi, Ferrari B.
    Berardi, D.
    [J]. JOURNAL OF PSYCHOSOMATIC RESEARCH, 2010, 68 (06) : 668 - 669
  • [30] ONE YEAR FOLLOW-UP LONGITUDINAL STUDYWITH A LARGE SAMPLE OF ANTIPSYCHOTIC-NAIVE CHILDREN AND ADOLESCENTS EXPOSED TO ANTIPSYCHOTICS
    Arango, Celso
    [J]. SCHIZOPHRENIA RESEARCH, 2012, 136 : S29 - S29
12345